GlyCoBrain Observational Study
Launched by PADERBORN UNIVERSITY · Nov 5, 2024
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background Breakfast is commonly considered one of the most important meals of the days. Failure to consume a breakfast, i.e., breakfast skipping, has been related to an increased risk of overweight/obesity or type 2 diabetes in the longer-term, but may also adversely affect cognition and academic performance. Similarly, breakfasts with a high glycaemic index (GI) resulting in sharp rises in blood glucose may adversely affect memory and attention, particularly in the late postprandial phase (i.e., 120-180 minutes after breakfast). A recent meta-analysis suggests specific effects for immedia...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Students at Paderborn University aged between 18 and 25 years
- • Proficient in the German language because all questionnaires are in German.
- Exclusion Criteria:
- • Students studying nutritional science and home economics
- * acute or permanent use of sleep-promoting medications (including herbal preparation):
- • chemical medications: melatonin, diphenhydramine, doxylamine
- • herbal preparations: hops, St. John's wort, lemon balm, lavender, passionflower, Baldurat, Neurexan, cannabinoids
- • Use of psychotropic medications (antidepressants, tranquilizer, antipsychotics)
- • Use of methylphenidate (e.g. Ritalin, Medikinet, Concerta)
- • Use of cannabinoids by prescription
- • Continuous administration of antihistamines when discontinuation is not feasible during the intervention
- • Use of herbal preparations affecting memory and concentration (e.g. gingko, ginseng, ashwagandha)
- • Use of other medications (e.g. insulin, metformin, SGLT2 inhibitors, steroids, ACE inhibitors)
- • Selected chronic diseases (depression and other mental disorders such as anxiety disorder, ADHD, diabetes mellitus (all types), prediabetes, blood clotting disorders (e.g., thrombocytopenia, hemophilia), eating disorders (e.g., anorexia, binge eating, bulimia)
- • Addiction disorders (e.g., alcohol, drug, or medication dependency)
- • Chronic inflammatory bowel diseases
- • infectious diseases (HIV, hepatitis)
- • Pregnant and breastfeeding individuals
- • Shift work or travel in the past 3 months across more than 2 time zones
- • students with a pacemaker/defibrillator
About Paderborn University
Paderborn University, a leading institution in research and education located in Germany, is committed to advancing scientific knowledge and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including medicine, engineering, and social sciences, to design and implement rigorous research studies. Paderborn University is dedicated to ensuring the highest ethical standards and regulatory compliance in its clinical trials, aiming to contribute valuable insights that enhance patient care and inform future medical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paderborn, North Rhine Westfalia, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported